--- a
+++ b/clusters/3009knumclusters/clust_69.txt
@@ -0,0 +1,186 @@
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
+Involvement in the planning and/or conduct of the study
+Patient has a history of non-compliance to medical regimen or inability to grant consent
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
+Patients planning to enroll in this study must first have a slot reserved in advance of the registration; all site staff will use OPEN to create a slot reservation
+History of noncompliance to medical regimens
+History of non-compliance to medical regimen or inability to grant consent
+Involvement in the planning and/or conduct of the study
+History of noncompliance to medical regimens
+Patient has a history of non-compliance to medical regimen or inability to grant consent
+Patients with a history of non-compliance to medical regimens or who are considered potentially unreliable or will not be able to complete the entire study
+History of noncompliance to medical regimens
+History of non-compliance to medical regimens
+History of non-compliance to medical regimens
+Patient has a history of non-compliance to medical regimen or inability to grant consent
+Participants who are involved in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
+Patient has a history of non-compliance to medical regimen or inability to grant consent
+Participants with involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
+Investigational site staff members directly involved in the conduct of the study and their family members, or Pfizer employees, including their family members, directly involved in the conduct of the study.
+History of noncompliance to medical regimens
+Involvement in study planning and conduct (i.e., Hansoh staff or staff at the study site).
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site); previous enrollment in the present study
+Patients with a history of non-compliance to medical regimens or who are considered potentially unreliable or will not be able to complete the entire study
+History of noncompliance to medical regimens
+History of noncompliance to medical regimens
+Patients with any significant history of non-compliance to medical regimens or with inability to grant a reliable informed consent
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site).
+Involvement in the planning and/or conduct of the study (applies to both investigator staff and/or staff at the study site)
+Involvement in the planning and/or conduct of the study (applies to AstraZeneca and/or Sarah Cannon Development Innovations staff and/or staff at the study site).
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
+Patients with any significant history of non-compliance to medical regimens or unwilling or unable to comply with the instructions given to them by the study staff
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at MD Anderson).
+Involvement in the planning and/or conduct of the study
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site), previous enrollment in the present study.
+Involvement in the planning and/or conduct of the study (applies to staff at the study site) or previous enrollment in the present study
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
+Investigator site staff members directly involved in the conduct of the study and their family members, site staff members otherwise supervised by the investigator, or patients who are Pfizer employees, including their family members, directly involved in the conduct of the study.
+Involvement in the planning and/or conduct of the study in the present study
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
+Patients with a history of non-compliance to medical regimens or who are considered potentially unreliable or will not be able to complete the entire study
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site).
+Involvement in the planning and/or conduct of the study
+History of noncompliance to medical regimens
+Involvement in the planning and/or conduct of the study (applies to AstraZeneca staff and/or staff at the study site)
+History of non-compliance to medical regimen or inability to grant consent
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site) or previous enrollment in the present study
+History of medical noncompliance
+History of non-adherence to medical regimens or inability to grant consent
+Patients with any significant history of non-compliance to medical regimens or with inability to grant a reliable informed consent
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site); previous enrollment in the present study
+History of noncompliance to medical regimens
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site) or previous enrollment in the present study
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site); previous enrollment in the present study
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site); previous enrolment in the present study
+Patients who are investigational site staff members directly involved in the conduct of the trial, and their family members, site staff members otherwise supervised by the investigator, or patients who are Archigen employees directly involved in the conduct of the trial.
+History of noncompliance to medical regimens
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site); previous enrolment or randomization in the present study
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
+Patients with any significant history of non-compliance to medical regimens or unwilling or unable to comply with the instructions given to him/her by the study staff
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site); previous enrollment or randomization in the present study
+Patients who are involved in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site); previous enrollment or randomization in the present study
+Any significant history of non-compliance to medical regimens or unwilling or unable to comply with the instructions given to him/her by the study staff
+Patients with a history of non-compliance to medical regimens or who are considered potentially unreliable or will not be able to complete the entire study
+A medical history of noncompliance with HAART or medical therapy
+History of noncompliance to medical regimens
+Patients with a history of non-compliance to medical regimens or who are considered potentially unreliable or will not be able to complete the entire study
+Patients with a history of non-compliance to medical regimens or who are considered potentially unreliable or will not be able to complete the entire study
+Patient with any significant history of non-compliance to medical regimens or with inability to grant reliable informed consent
+Patients with any significant history of non-compliance to medical regimens or with inability to grant a reliable informed consent
+History of noncompliance to medical regimens
+History of noncompliance with medical regimens
+Patients unable to communicate with the investigator and staff.
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site).
+safety of study staff
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
+Involvement in the planning and/or conduct of the study
+Patient has a history of noncompliance to medical regimens or is unable to grant consent.
+History of noncompliance to medical regimens
+Involvement in the planning and/or conduct of the study
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site); previous enrollment in the present study
+A medical history of noncompliance with HAART or medical therapy
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and staff at University of Iowa Hospitals and Clinics [UIHC])
+Patient has a history of non-compliance to medical regimen or inability to grant consent
+Patient has a history of non-compliance to medical regimen or inability to grant consent
+Patient has a history of non-compliance to medical regimen or inability to grant consent
+Patient has a history of non-compliance to medical regimen or inability to grant consent
+Patients with any significant history of non-compliance to medical regimens or unwilling or unable to comply with the instructions given to him/her by the study staff
+History of noncompliance to medical regimens
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
+Patient with any significant history of non-compliance to medical regimens or with inability to grant reliable informed consent
+safety of study staff
+History of non-compliance to medical regimens
+Patient has a history of non-compliance to medical regimen.
+Patient has a history of non-compliance to medical regimen or inability to grant consent
+Patients with any significant history of non-adherence to medical regimens or with inability to grant reliable informed consent
+Patients with a history of non-compliance to medical regimens or who are considered potentially unreliable or will be unable to complete the entire study.
+Immediate family member who is investigational site or sponsor staff directly involved with this study
+History of non-compliance to medical regimens or inability to grant consent
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site).
+Patient has a history of non-compliance to medical regimen or inability to grant consent
+Patients with a history of non-compliance to medical regimens or who are considered potentially unreliable or will not be able to complete the entire study
+Patients with any significant history of non-compliance to medical regimens or with inability to grant reliable informed consent
+History of noncompliance to medical regimens.
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca, contract research organization [CRO] staff, and/or staff at the central processing unit [CPU])
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site); previous enrollment in the present study
+Patient has a history of non-compliance to medical regimen or inability to grant consent
+History of non-compliance to medical regimens
+History of noncompliance to medical regimens or unwillingness to comply with the protocol
+History of non-compliance to medical regimens
+Patient has a history of non-compliance to medical regimen or inability to grant consent
+Participants with any significant history of non-compliance to medical regimens or unwilling or unable to comply with the instructions given to him/her by the study staff
+Involvement in the planning and/or conduct of the study
+History of non-compliance to medical regimens or who are considered potentially unreliable or will not be able to complete the entire study
+Patient has a known history of non-compliance to medical regimen or inability to grant consent
+Patients with a history of non-compliance to medical regimens or who are considered potentially unreliable or will not be able to complete the entire study
+Patients with a history of non-compliance to medical regimens or who are considered potentially unreliable or will not be able to complete the entire study
+Patients with a history of non-compliance to medical regimens or who are considered potentially unreliable or will not be able to complete the entire study
+Patients with a history of non-compliance to medical regimens or who are considered potentially unreliable or will not be able to complete the entire study
+History of noncompliance to medical regimens
+Patients with any significant history of non-compliance to medical regimens or unwilling or unable to comply with the instructions given to them by the study staff
+Involvement in the planning and/or conduct of the study
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff, its agents and/or staff at the study site).
+Participants with any significant history of non-compliance to medical regimens or unwilling or unable to comply with the instructions given to him/her by the study staff
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site).
+safety of study staff
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site).
+History of noncompliance to medical regimens
+History of noncompliance to medical regimens or patients who are considered potentially unreliable not cooperative
+History of noncompliance to medical regimens
+History of noncompliance to medical regimens or coexisting -
+Patients with any significant history of non-compliance to medical regimens or unwilling or unable to comply with the instructions given to him/her by the study staff
+History of non-compliance to medical regimens or inability to grant consent
+Patients with a history of non-compliance to medical regimens or who are considered potentially unreliable or will not be able to complete the entire study
+History of noncompliance to medical regimens
+Patients with any significant history of non-compliance to medical regimens or unwilling or unable to comply with the instructions given to him/her by the study staff.
+History of noncompliance to medical regimens
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
+Involvement in the planning and/or conduct of the study (applied to both AstraZeneca staff and/or staff at the study site); previous enrollment in the previous study
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca Representative staff and/or staff at the study site);
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
+History of non-compliance with medical regimen, or patients potentially unreliable and/or not cooperative
+Patients who are investigational site staff members directly involved in the conduct of the trial and their family members, site staff members otherwise supervised by the Investigator, or patients who are Pfizer employees directly involved in the conduct of the trial.
+History of non-compliance to medical regimens
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
+Patients with a history of non-compliance to medical regimens or who are considered potentially unreliable or will not be able to complete the entire study
+History of non-compliance to medical regimens or inability to grant consent
+History of non-compliance to medical regimens
+Patients with any significant history of non-compliance to medical regimens or unwilling or unable to comply with the instructions given to him/her by the study staff
+History of noncompliance to medical regimens
+Patient has a history of non-compliance to medical regimen or inability to grant consent.
+Patient is a staff member of the sponsor or clinical site and is involved in the conduct of the study or the relative of such a staff member. Patient Exclusion Criteria - Part 2:
+Patient is a staff member of the sponsor or clinical site and is involved in the conduct of the study or the relative of such a staff member
+Patients with any significant history of non-compliance to medical regimens or unwilling or unable to comply with the instructions given to him/her by the study staff
+History of noncompliance to medical regimens
+Patients with any significant history of non-compliance to medical regimens or unwilling or unable to comply with the instructions given to him/her by the study staff
+Patients with any significant history of non-compliance to medical regimens or with inability to grant a reliable informed consent
+Subjects who are part of the staff personnel directly involved with this study
+Subjects who are family members of the investigational study staff
+A medical history of noncompliance with HAART or medical therapy
+History of noncompliance to medical regimens
+Patients with any significant history of non-compliance to medical regimens or unwilling or unable to comply with the instructions given to him/her by the study staff.
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
+Patient has a history of non-compliance to medical regimen or inability to grant consent
+Patients with a history of noncompliance to medical treatments and/or considered potentially unreliable
+CLINICAL STAFF: Nurses, physicians, physician assistants, or support staff and perform direct patient care in the thoracic oncology clinic
+Patients unable to communicate with the investigator and staff.
+Patients with a history of non-compliance to medical regimens or who are considered potentially unreliable or will not be able to complete the entire study
+History of non-compliance to medical regimens
+Patients with a history of non-compliance to medical regimens or who are considered potentially unreliable or will not be able to complete the entire study
+Family member of the investigation study staff
+Patients with a history of non-compliance to medical regimens or who are considered potentially unreliable or will not be able to complete the entire study
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
+Involvement in the planning and conduct of the study (applies to both Astra Zeneca staff and staff at the study site)
+Is or has an immediate family member who is investigational site or sponsor staff directly involved with this study
+Patients with a history of non-compliance to medical regimens or who are considered potentially unreliable or will not be able to complete the entire study or patient diaries;
+Not able to communicate meaningfully with the Investigator and site staff.
+Involvement in the planning and/or conduct of the study (applies to both AstraZeneca, Contract Research Organization [CRO] staff, and/or staff at the CPU)
+History of medical noncompliance
+Oncology providers and staff at the University of Pittsburgh Medical Center (UPMC)
+Ability to independently complete the study as assessed by the research staff